21 Fanconi Anemia Clinical Trials in Minneapolis, MN (2026)

Q: Are there fanconi anemia clinical trials in Minneapolis?

Yes, there are 21 fanconi anemia clinical trials currently recruiting in Minneapolis, MN.

Q: How do I join a clinical trial in Minneapolis?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you.

Q: Are clinical trials in Minneapolis free?

Yes, clinical trial participation is always free. Study-related treatments, medical tests, and doctor visits are provided at no cost.

Recruiting Fanconi Anemia Studies in Minneapolis

NCT00785525Recruiting

Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors

The purpose of the study is to: * Establish and evaluate a system for collection of filgrastim-mobilized peripheral blood stem cells from National Marrow Donor Program donors (NMDP) donors * Assess t...

Minneapolis, MNPHASE360,000 participantsCenter for International Blood and Marrow Transplant Research

View Study Details

NCT04077762Recruiting

Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)

This is a phase IV, prospective, open label, randomized-controlled study that will compare radial access with state-of-the-art femoral access in patients without ST-segment elevation acute myocardial ...

Minneapolis, MNNA3,266 participantsMinneapolis Heart Institute Foundation

View Study Details

NCT06934876Recruiting

Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults

This study will compare the sensitivity and specificity of waveform capnography versus colorimetric carbon dioxide detection to identify tracheal placement of the endotracheal tube during intubation o...

Minneapolis, MN2,092 participantsBrian Driver

View Study Details

NCT06425848Recruiting

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmo...

Minneapolis, MN2,000 participantsUniversity of Kansas Medical Center

View Study Details

NCT04334707Recruiting

Kidney Precision Medicine Project

Acute kidney injury (AKI) and chronic kidney disease (CKD) impose a significant global health burden. Yet, no effective therapies currently exist for AKI, and only a few are available for CKD. Despit...

Minneapolis, MN1,000 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT06994442Recruiting

Optimizing Pain Treatment in Children On Mechanical Ventilation

In this clinical trial, investigators want to learn more about using non-opioid pain medications for children with acute respiratory failure. Right now, doctors give these children opioids to help wit...

Minneapolis, MNPHASE3644 participantsWeill Medical College of Cornell University

View Study Details

NCT05744973Recruiting

Multi-level Predictors of Structural Racism and Discrimination and Associations With Health and Well-being Across the Life Course in Diverse Families

Minoritized populations face mutually reinforcing levels of structural disadvantage that contribute to poor health. Despite recognition that social and economic stratification, environmental condition...

Minneapolis, MN631 participantsUniversity of Colorado, Denver

View Study Details

NCT07131631Recruiting

Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance

This is a multi-center, prospective, observational study designed to evaluate the impact of LV myocardial fibrosis extent assessed by CMR on LV reverse remodeling and clinical outcomes post TEER. The ...

Minneapolis, MN125 participantsMinneapolis Heart Institute Foundation

View Study Details

NCT03523416Recruiting

Early Feasibility Study - Edwards APTURE Transcatheter Shunt System

The purpose of this study is to evaluate initial clinical safety, device functionality and effectiveness of the Edwards APTURE transcatheter shunt system....

Minneapolis, MNNA90 participantsEdwards Lifesciences

View Study Details

NCT05604131Recruiting

Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients

The objective of this randomized, controlled pilot study is to determine the efficacy of Deferiprone to reduce the amount of free iron inside the hemorrhagic zone of myocardial infarction among hemorr...

Minneapolis, MNPHASE289 participantsRohan Dharmakumar

View Study Details

NCT07649031Recruiting

MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients

This study being done to learn more about the use of medical Magnetic Resonance Imaging (mMRI) and dedicated dental MRI (ddMRI) as a non-invasive diagnosing tool when evaluating potential oral cancero...

Minneapolis, MN80 participantsUniversity of Minnesota

View Study Details

NCT05843396Recruiting

Brain Organization, Development, and Response to Intervention in Individual Neonates

The goal of this study is to learn about brain connectivity and if massaging babies shortly after birth has an impact. Half of the recruited babies will receive massage daily while the other half will...

Minneapolis, MNNA80 participantsWashington University School of Medicine

View Study Details

NCT07201922Recruiting

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

This study is open to people aged 40 years or older who have at least 1 family member with pulmonary fibrosis. Pulmonary fibrosis is a condition where lung tissue becomes scarred, making it harder to ...

Minneapolis, MNPHASE380 participantsBoehringer Ingelheim

View Study Details

NCT06872333Recruiting

Allo HSCT for High Risk Hemoglobinopathies

A single center, open label, interventional, phase II trial for donor transplant for high risk hemoglobinopathies and other red cell transfusion dependent disorders utilizing allogeneic hematopoietic ...

Minneapolis, MNPHASE262 participantsMasonic Cancer Center, University of Minnesota

View Study Details

NCT01581424Recruiting

Natural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal Disease Study

The investigators will perform a study with two major components. The first is a natural history study of untreated Fabry patients. This study component will detail kidney microscopic structural chang...

Minneapolis, MN50 participantsUniversity of Minnesota

View Study Details

NCT02161783Recruiting

Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation

This is a guideline for the treatment of graft failure after hematopoietic stem cell transplant (HSCT). This regimen, consisting of cyclophosphamide and fludarabine with low dose total body irradiatio...

Minneapolis, MN50 participantsMasonic Cancer Center, University of Minnesota

View Study Details

NCT03579875Recruiting

Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders

This is a phase II trial of T cell receptor alpha/beta depletion (α/β TCD) peripheral blood stem cell (PBSC) transplantation in patients with inherited bone marrow failure (BMF) disorders to eliminate...

Minneapolis, MNPHASE248 participantsMasonic Cancer Center, University of Minnesota

View Study Details

NCT06360380Recruiting

Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System

The REFORM-HF study aims to test a new technology, AQUAPASS, designed to assist patients experiencing symptoms of fluid overload due to Heart Failure. Patients will wear a lightweight suit that helps...

Minneapolis, MNNA40 participantsAquaPass Medical Ltd.

View Study Details

NCT06270316Recruiting

Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease

The main goals of this clinical study are to characterize safety and PK/PD of AMT-191 i.e. if drug doses used in the study are safe and tolerable and to understand how it acts in the body of people wi...

Minneapolis, MNPHASE120 participantsUniQure Biopharma B.V.

View Study Details

NCT06858397Recruiting

A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease

This Phase 1/2 first-in-human (FIH) study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of HM15421 in patients with FD....

Minneapolis, MNPHASE118 participantsGC Biopharma Corp

View Study Details

NCT06904261Recruiting

A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants

An open-label study to evaluate the safety, pharmacokinetics (PK), pharmacodynamics (PD), and efficacy of migalastat treatment in pediatric subjects 2 to \< 12 years of age with Fabry disease and with...

Minneapolis, MNPHASE38 participantsAmicus Therapeutics

View Study Details

About Fanconi Anemia Clinical Trials in Minneapolis

Fanconi anemia is a rare genetic disorder that affects bone marrow, reducing production of all types of blood cells and increasing cancer susceptibility. It is associated with physical abnormalities and organ defects. Treatment includes blood transfusions, growth factors, and stem cell transplant.

There are currently 21 fanconi anemia clinical trials recruiting participants in Minneapolis, MN. These studies are seeking a combined 70,473 participants. Research is being sponsored by Center for International Blood and Marrow Transplant Research, Minneapolis Heart Institute Foundation, Brian Driver and 14 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fanconi Anemia Clinical Trials in Minneapolis — FAQ

Are there fanconi anemia clinical trials in Minneapolis?

Yes, there are 21 fanconi anemia clinical trials currently recruiting in Minneapolis, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Minneapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.

Are clinical trials in Minneapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.

What fanconi anemia treatments are being tested?

The 21 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for fanconi anemia.

Data updated October 12, 2026 from ClinicalTrials.gov